Piramal Pharma Ltd.

NSE: PPLPHARMA | BSE: 543635 | ISIN: INE0DK501011 | Industry: Pharmaceuticals
| Expensive Performer
160.5300 -2.52 (-1.55%)
NSE Feb 20, 2026 15:31 PM
Volume: 2.0M
 

160.53
-1.55%
ICICI Direct
PPL owns 17 development and manufacturing facilities across India, US and UK with capabilities in sterile, API, formulations, drug discovery and manufacturing of nutrition products. The company holds 49% stake in AbbVie Therapeutics, JV with...
Piramal Pharma Ltd. is trading below all available SMAs
More from Piramal Pharma Ltd.
Recommended